Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reduced immunogenicity of MYC amplified, metastatic prostate cancer. | Oncoscience | 2026 | 41743583 | PubTator, text mining | PubMed |
| Pre-procedural left atrial strain and clinical features for predicting recurrence after first catheter ablation of persistent atrial fibrillation: a prospective cohort study. | Front Cardiovasc Med | 2026 | 41736830 | PubTator, text mining | PubMed |
| Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recovery. | Sci Rep | 2026 | 41720832 | PubTator, text mining | PubMed |
| SNRPD2-mediated regulation of DDX39B splicing promotes endometrial cancer progression by suppressing the activation of CTSC cryptic exons. | Cell Death Dis | 2026 | 41720762 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma. | Med Sci (Basel) | 2026 | 41718124 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Activity of (E)-α-Fluorovinylphosphonate-Based Reversible Cathepsin C Inhibitors. | J Org Chem | 2026 | 41685724 | PubTator, text mining | PubMed |
| Brensocatib-Another Therapeutic "Window of Opportunity" for Patients with Bronchiectasis. | J Clin Med | 2026 | 41682938 | PubTator, text mining | PubMed |
| RNAseq-based meta-analyses revealed tumor suppressor-inducer fusion events in liver, oral, and ovarian cancer in the Indian population: a cancer cell surviving mechanism. | Nucleosides Nucleotides Nucleic Acids | 2026 | 41661231 | PubTator, text mining | PubMed |
| Patients' experiences of penicillin allergy evaluation: a qualitative study. | JAC Antimicrob Resist | 2026 | 41647664 | PubTator, text mining | PubMed |
| The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap. | Drugs Context | 2026 | 41641011 | PubTator, text mining | PubMed |
| Identity of protease-based biomarkers for viability and cytotoxicity revealed by CRISPR knockouts. | Anal Biochem | 2026 | 41638522 | PubTator, text mining | PubMed |
| Diketopyrrolopyrrole-based two-dimensional poly(arylene vinylene)s with high charge carrier mobility. | Nat Commun | 2026 | 41634010 | PubTator, text mining | PubMed |
| Dimethyl fumarate as a versatile therapeutic agent: molecular mechanisms and potential clinical applications. | Mol Biol Rep | 2026 | 41627610 | PubTator, text mining | PubMed |
| Anti-inflammatory therapies for bronchiectasis. | Curr Opin Infect Dis | 2026 | 41593454 | PubTator, text mining | PubMed |
| Pharmacokinetics and Safety of a Single Dose of Brensocatib in Participants with Hepatic Impairment and Matched Participants with Normal Hepatic Functions. | Clin Pharmacokinet | 2026 | 41586857 | PubTator, text mining | PubMed |
| Prosaposin Is Cleaved Into Saposins by Multiple Cathepsins in a Progranulin-Regulated Fashion. | J Neurochem | 2026 | 41572567 | PubTator, text mining | PubMed |
| Neutrophils as critical orchestrators of chronic inflammation. | Cell Mol Immunol | 2026 | 41530536 | PubTator, text mining | PubMed |
| Tumor-derived neutrophil extracellular trap-associated DNA impairs treatment efficacy in breast cancer via CCDC25-dependent epithelial-mesenchymal transition. | J Clin Invest | 2026 | 41480760 | PubTator, text mining | PubMed |
| Exacerbation risk in patients with bronchiectasis receiving DPP-1 inhibitors vs placebo: A meta-analysis of RCTs. | Respir Med | 2026 | 41443427 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine derivatives as cathepsin L inhibitor for the treatment of acute lung injury. | Eur J Med Chem | 2026 | 41389412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=4